PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway by Vij, Neeraj et al.
PDGF-driven proliferation, migration, and IL8 chemokine
secretion in human corneal fibroblasts involve JAK2-STAT3
signaling pathway
Neeraj Vij,1 Ajay Sharma,1,3 Mahesh Thakkar,3,4 Sunilima Sinha,1,3 Rajiv R. Mohan1,2,3
1Mason Eye Institute, School of Medicine, University of Missouri-Columbia, Columbia, MO; 2College of Veterinary Medicine,
University of Missouri-Columbia, Columbia, MO; 3Harry S. Truman Memorial Veterans Hospital, Columbia, MO; 4Department of
Neurology, University of Missouri, Columbia, MO
Purpose: Platelet-derived growth factor (PDGF) is associated with corneal fibroblast migration and proliferation and
plays an important role in corneal wound healing. However, the intracellular mechanisms of PDGF-mediated functions
in corneal fibroblasts are poorly understood. We tested the hypothesis that PDGF functional activities in the cornea involve
the Janus kinase-2/signal transducers and activators of transcription-3 (JAK2-STAT3) signaling pathway and whether
PDGF induces the expression of suppressors of cytokine signaling 3 (SOCS3), belonging to the novel family of feedback
regulators of cytokine and growth factor activities.
Methods: Human corneal fibroblast (HSF) cultures were used as an in vitro model for functional analysis. Real-time
polymerase chain reactions were performed to quantify gene expression. Immunoprecipitation and immunoblotting
techniques were used to measure protein expression. Cell growth, migration, and ELISA assays were used for functional
validation.
Results: Low endogenous levels of STAT3 and SOCS3 mRNA and protein expression were noted in HSFs. PDGF
treatment of HSF significantly induced SOCS3 mRNA (3.0–4.5 fold) and protein (1.5–2.5 fold) expression in a time-
dependent manner. Similarly, PDGF treatment of HSF significantly increased STAT3 protein expression at two tested
time points (2.5–2.96 fold). Cultures exposed to vehicle (control) did not show any change in SOCS3 and STAT3 mRNA
or protein expression. An addition of AG-490, a selective inhibitor of the JAK2-STAT3 pathway, significantly inhibited
PDGF-mediated  STAT3  induction  and  cell  growth  and  migration  in  HSF.  We  also  observed  that  PDGF  induced
interleukin-8 (IL8) chemokine secretion (2 fold) and AG-490 inhibited IL8 secretion.
Conclusions: Our data showed that PDGF induced STAT3, SOCS3, and IL8 chemokine secretion in human corneal
fibroblasts. Further, PDGF-induced cell growth, migration, and IL8 secretion in corneal fibroblast involve the JAK2-
STAT3 signaling pathway.
Corneal  wound  healing  plays  a  critical  role  in  the
maintenance  of  corneal  transparency  and  visual  acuity.
Corneal epithelial cell migration and proliferation, keratocyte
apoptosis,  extracellular  matrix  remodeling,  and
transdifferentiation  of  keratocyte  to  fibroblasts  and
myofibroblasts are involved in corneal wound healing [1-3].
These processes are largely regulated by the cytokines and
growth factors through the activation of several intracellular
signaling  pathways  including  those  involving  mitogen-
activated proteins (MAP) kinases, Janus kinases (JAKs), and
signal transducers and activators of transcription (STATs)
[4-6]. Recently, a family of inhibitory molecules called the
suppressors of cytokine signaling (SOCS) proteins have been
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described [7,8]. These proteins have highly divergent amino
termini,  a  central  Src-homology  2  (SH2)  domain,  and  a
conserved COOH-terminal region known as the SOCS box.
Cytokines  rapidly  induce  SOCS  expression,  and  SOCS
proteins  in  turn  regulate  cytokine  signal  transduction  and
STAT activation negatively either through inhibition of JAK
kinases or by direct binding to signaling chains in the receptor
complex [7]. Mutational analysis of SOCS1 has established
that both the NH2-terminus and SH2 domain are essential for
blocking JAK activity and cytokine signaling, but the COOH-
terminal SOCS-box region is not required. Furthermore, the
SH2 domain is necessary but not sufficient to inhibit JAK
activity  [9,10].  Another  SOCS  protein,  SOCS3,  can  be
induced  by  many  cytokines  and  growth  factors  such  as
interleukin  (IL)-2,  IL3,  leptin,  and  insulin  [8,9,11].  The
expression of SOCS3 is rapidly induced in T cells in response
to  IL2  and  can  strongly  inhibit  IL2-induced  STAT5
phosphorylation [11]. Unlike other SOCS proteins, SOCS3 is
rapidly  tyrosine-phosphorylated  after  IL2  stimulation,
although  the  importance  of  this  phosphorylation  is  still
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1020unclear [11]. Although SOCS proteins inhibit the JAK/STAT
pathway, their function in the modulation of other signaling
pathways is unknown. Recently, SOCS gene expression has
been shown to be induced by many cytokines and growth
factors including the platelet-derived growth factor (PDGF)
[12]. Gene microarray analysis of PDGF-stimulated human
corneal fibroblasts showed a significant increase in SOCS3
expression [13].
Cytokines  and  chemokines  also  regulate  immune
response  by  regulating  proliferation  and  migration  of
inflammatory and other cells to help in the process of wound
healing  [14-17].  A  proinflammatory  cytokine,  IL8,  is
produced  by  epithelial  and  fibroblast  cells  and  plays  an
important role in inflammation and wound healing [18,19].
IL8 has a capacity to recruit T-cells as well as nonspecific
inflammatory cells into sites of inflammation by activating
neutrophils [20]. IL8 has been shown to stimulate α-smooth
muscle actin production in human fibroblasts when applied to
the excision wounds in chickens and causes the wounds to
contract and close more rapidly [21]. Furthermore, IL8 is
chemotactic for fibroblasts and accelerates their migration and
can stimulate deposition of tenascin, fibronectin, and collagen
I during wound healing in vivo [21]. Both human corneal
keratocytes and epithelial cells have been shown to synthesize
and  release  IL8  following  cytokine  stimulation  and/or
infection [22,23].
Platelet-derived  growth  factor  (PDGF)  is  a  known
modulator of fibroblast cell mitosis and chemotaxis [24-26].
Earlier, we have demonstrated the expression of PDGF-AA,
PDGF-BB, and PDGF-AB and their receptors in the human
cornea and their role in proliferation and chemotaxis using
cultured  human  corneal  fibroblasts  [27].  Out  of  the  three
tested  isoforms,  PDGF-BB  demonstrated  a  significantly
higher chemotactic effect compared to PDGF-AA or PDGF-
AB in human corneal fibroblasts [27]. Interestingly, PDGF-
AA showed strongest chemotactic response in rabbit corneal
epithelial cells [28]. Because of the chemotactic role of PDGF
in  corneal  wound  healing,  we  hypothesized  that  PDGF
regulates the neutrophil chemoattractant, IL8. IL8 is known
to  enhance  corneal  wound  healing  by  chemoattracting
leukocytes and fibroblasts into the wound site rapidly [29,
30]. We anticipated PDGF-mediated SOCS3 overexpression
as  a  mechanism  to  regulate  corneal  inflammation  and
hypothesized that PDGF regulates IL8 chemokine secretion
to promote cell migration and aids in other processes of wound
repair and healing. The intracellular signaling mechanisms of
PDGF-induced  fibroblast  migration,  proliferation,  and
corneal wound healing are poorly understood. Jester et al.
[31] reported that PDGF has a synergistic effect on TGFβ-
induced  transformation  of  rabbit  corneal  keratocytes  to
myofibroblasts  and  proposed  that  PDGF  is  an  important
mediator of wound healing. A recent report on skin fibroblasts
suggests  that  STAT3  is  involved  in  PDGF-driven  cell
migration, and this process is negatively regulated by SOCS3
[32]. A significant increase in SOCS3 transcript levels by
PDGF  in  human  corneal  fibroblasts  noted  on  gene  array
analysis together with our previous investigations with PDGF
prompted  us  to  hypothesize  that  PDGF-mediated  cellular
proliferation  and  migration  in  cornea  involve  JAK/STAT
pathway  under  negative  feedback  regulation  by  SOCS3.
Using cultured human corneal fibroblasts, we showed that
PDGF-induced cellular proliferation and migration involves
JAK2-STAT3 pathway under the regulation of SOCS3.
METHODS
Cell culture: Donor human corneas were procured from the
Hartland Eye Banks (St. Louis, MO). Primary human corneal
fibroblasts (HSF) were generated from donor human corneas
using a method described previously [33]. Briefly, the cornea
was washed with an HSF medium, and the epithelium and
endothelium were removed by gentle scraping with a scalpel
blade.  The  corneal  stroma  was  cut  into  small  pieces  and
incubated in humidified CO2 incubator at 37 °C in Dulbecco’s
modified  Eagle’s  medium  (DMEM)  containing  10%  fetal
bovine  serum  to  obtain  HSF.  Seventy  percent  confluent
cultures of HSF (passages 1–3) were used for experiments. To
investigate the effect of PDGF, a mixture of PDGF containing
equal amounts of PDGF-AA, PDGF-AB, and PDGF-BB was
used for all experiments. Cultures were exposed to the mixture
of PDGF (AA, AB, and BB) at a final concentration of 20 ng/
ml for 1 h or 8 h. The JAK-STAT inhibitor, AG-490, was used
at 100 μM final concentration for the indicated time to inhibit
downstream signaling. For all the experiments, cultures were
serum-starved for 24 h before being exposed to the cytokine
and/or the inhibitor. The cytokines were bought from R&D
System (Minneapolis, MN), and the AG-490 inhibitor was
purchased from Calbiochem (San Diego, CA).
RNA extraction, cDNA synthesis, and quantitative real-time
polymerase chain reaction: Total RNA from the cells was
extracted using an RNeasy kit (Qiagen Inc., Valencia, CA)
and was reverse transcribed to cDNA (Promega, Madison,
WI) following the vendor’s instructions using the ImProm-II
Reverse  Transcription  kit.  Real-time  polymerase  chain
reaction (PCR) was performed using the iQ5 real-time PCR
Detection  System  (Bio-Rad  Laboratories,  Hercules,  CA).
Fifty microliters of a reaction mixture containing 2 µl cDNA
(250 ng), 2 µl forward primer (5′-TGG CGA AGG AAA TGG
TCA CA-3′; 200 nM), 2 µl reverse primer (5′-GGT GAC TGT
CCC GGA GGA GA-3′; 200 nM), and 25 µl 2X iQ SYBR
Green Supermix (Bio-Rad Laboratories) was run at universal
cycle (95 °C for 3 min, 40 cycles of 95 °C for 30 s followed
by  60  °C  for  60  s)  according  to  the  manufacturer’s
instructions. The β-actin forward primer (5′-CGG CTA CAG
CTT CAC CAC CA-3′) and reverse primer (5′-CGG GCA
GCT CGT AGC TCT TC-3′) were used as a housekeeping
gene. The threshold cycle (Ct) was used to detect the increase
in the signal associated with an exponential growth of PCR
product during the log-linear phase. The relative expression
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1021was calculated using the following formula, 2-ΔΔCt. The ΔCt
validation  experiments  showed  similar  amplification
efficiency for all templates used (the difference between linear
slopes for all templates is less than 0.1). Three independent
experiments  were  performed  and  the  average  (±SEM;
standard error of the mean) results are presented in graphic
form.
Immunoprecipitation  and  immunoblotting:  Cells  were
washed three times in ice-cold PBS and lysed directly on
plates using M-PER protein lysis buffer containing protease
inhibitor  cocktail  (Pierce  Biotech,  Rockford,  IL).  To
immunoprecipitate  SOCS3,  we  used  1000  µg/ml  of  total
corneal fibroblast protein extracts and incubated them with 50
µl of protein A/G agarose beads (Santa Cruz Biotechnology
Inc., Santa Cruz, CA) for 3 h at 4 °C. After preclearing, 5 µl
of 1 mg/ml SOCS3 goat polyclonal antibody (Santa Cruz
Biotechnology Inc.) was added to each treatment group and 5
µl of pre-immune serum served as the negative control [34].
Protein A/G agarose beads (50 µl) were added to each tube
after 1 h followed by overnight incubation at 4 °C. Beads were
washed once with lysis buffer (20 mM Tris-HCl, pH 7.6;
150  mM  NaCl;  0.5%  Triton  X-100;  and  10  µM
phenylmethylsulfonyl  fluoride)  followed  with  two  washes
with PBS. The samples were suspended in Laemmli’s sample
buffer (30 µl), vortexed for 1 min, centrifuged for 5 min at
10,000x g, and boiled for 5 min. For immunoblotting, the
protein extracts were suspended in 30 µl of Laemmli’s sample
buffer containing β-mercaptoethanol, resolved by 4%–10%
SDS–PAGE,  and  transferred  to  a  0.45-µm  pore  size
nitrocellulose membrane (Invitrogen, San Diego, CA) [35].
The STAT3, SOCS3, and β-actin antibodies were purchased
from Santa Cruz Biotech. The anti-mouse, rabbit- or goat-
HRP, or AP antibodies were from Amersham (Piscataway,
NJ) or Santa Cruz Biotech.
Interleukin-8  ELISA:  Corneal  fibroblast  cultures  (~70%
confluence) were serum-starved for 24 h and stimulated with
PDGF for 8 h. At end-time points, supernatants were collected
from  three  independent  experiments  and  IL8  levels  were
measured  using  solid-phase  amplified  sensitivity
immunoassay  as  specified  by  the  manufacturer  (ELISA
system,  BioSource  Europe  S.A,  Nivelles,  Belgium).
Standards and cytokine controls were included. The plates
were  read  at  450  nm  on  a  96-well  microplate  reader
(Molecular Devices, Sunnyvale, CA) using SOFT-MAX-Pro
software (Molecular Devices). The mean blank reading was
subtracted from each sample and control reading. A standard
curve was plotted, and an IL8 concentration in each sample
was  determined  by  interpolation  from  the  standard  curve
[36].  The  data  represents  the  mean  of  three  independent
experiments ±SEM .
Cell proliferation assay: To assess the effect of PDGF on
corneal  fibroblast  proliferation,  a  viable  cell  number  was
counted  using  a  3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl
tetrazolium  bromide  (MTT)-based  method  as  described
previously [37]. The assay utilizes a tetrazolium compound,
MTT (Sigma-Aldrich, St Louis, MO), that is bio-reduced by
viable  cells  to  a  purple  colored  formazan  product
(proportional to the number of viable cells), which can be
detected by measuring its absorbance at 570 nm. Using a 96
well plate, 2x103 cells were plated in each well in 100 μl of
DMEM, and 10 μl of MTT reagent was added to each well.
Wells containing media alone without cells served as the
negative controls. The plates were incubated for 2 h at 37 °C
in a humidified 5% CO2 incubator. To study the effect of
PDGF on cell growth, 20 ng/ml of PDGF (an equal mixture
of AA, AB, and BB) was added in each well. Four replicates
of each treatment were used for each experiment. Absorbance
was recorded at 570 nm using a 96 well plate reader (BioTEk
FLx 800, Winooski, VT).
Cell  migration  assay:  The  48  well  Boyden  chemotaxis
chamber apparatus (Neuro Probe, Gaithersburg, MD) was
used for the chemotaxis assay using polyvinyl pyrrolidine-
free polycarbonate filters with a thickness of 10 μm and pore
size  of  8  μm.  Cell  migration  assay  was  performed  as
previously described [27]. Briefly, polycarbonate filters were
precoated with collagen type I solution (Sigma-Aldrich, St.
Louis, MO). Thirty microliters of DMEM having no cytokine
or  cells  was  placed  in  the  lower  chamber  of  the  Boyden
apparatus, and after placing the polycarbonate filter, 50 μl of
DMEM containing 20 ng/ml of PDGF and 15,000 HSF was
placed in the upper chamber. The apparatus was incubated in
humidified CO2 at 37 °C for the desired duration. The total
number of cells migrated to the lower side of the membrane
were counted from three independent experiments at 1 h and
8 h time points following methods reported earlier [27].
Image and statistical analysis: The results were expressed as
mean±standard error of the mean (SEM) of three to four
replicates  as  indicated.  Statistical  analysis  was  performed
using two-way analysis of variance (ANOVA) followed by
Bonferroni multiple comparisons test for real-time PCR and
cellular proliferation data. The cellular migration and IL8
ELISA  results  were  analyzed  using  one-way  ANOVA
followed by Tukey’s multiple comparison test. A p-value less
than  0.05  was  considered  significant.  The  gel  data  was
analyzed using Image J 1.38 X image analysis software (NIH,
Bethesda, MD).
RESULTS
Platelet-derived  growth  factor  mediates  suppressor  of
cystokine-3 induction in corneal fibroblasts: We quantified
the suppressor of cystokine-3 (SOCS3) mRNA and protein
levels in human corneal fibroblasts by real-time PCR and
immunoprecipitation,  respectively.  The  quantitative  PCR
detected low endogenous SOCS3 expression in HSF, and
PDGF treatment resulted in a threefold increase in SOCS3
RNA expression at 1 h and 4.25 fold increase at 8 h (Figure
1A). The addition of AG-490 (100 μM), a selective inhibitor
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1022of JAK2-STAT3 pathway, caused 29% and 45% (p<0.05)
reduction in PDGF-induced SOSC3 levels at 1 h and 8 h,
respectively (Figure 1A). These results were in agreement
with the findings of the PDGF-exposed HSF cDNA analysis
carried with Affymetrix HG-U133 GeneChip system [13].
The  PDGF-stimulated  HSF  samples  revealed  through
immunoprecipitation  a  1.5  fold  and  2.5  fold  increase  in
SOCS3 protein levels at 1 h and 8 h, respectively (Figure 1B).
The vehicle-treated control samples did not show any change
in  SOCS3  mRNA  (Figure  1A)  or  protein  (Figure  1B)
expression.
Platelet-derived  growth  factor-driven  STAT3  induction  is
JAK2-STAT3 mediated: Activation of STAT3 is known to
induce SOCS3 expression as a negative feed back mechanism.
To test the hypothesis that PDGF-induced SOCS3 increase is
STAT3-mediated in HSF, we determined the changes in the
STAT3  levels  in  HSF  treated  with  PDGF.  Western  blot
analysis  of  STAT3  demonstrated  2.5  fold  and  2.96  fold
increases in STAT3 levels at 1 h and 8 h, respectively, in the
PDGF-stimulated HSF (Figure 2). The addition of AG-490
(100 μM), a selective inhibitor of JAK/STAT pathway, caused
about 40% reduction in PDGF-induced STAT3 levels in HSF
(1.6–2.0 fold; Figure 2).
Platelet-derived  growth  factor  induces  interleukin-8
chemokine secretion via JAK2-STAT3 pathway: The role of
PDGF in corneal wound healing [27,28,31] and IL8-mediated
neutrophil  chemotaxis  [12,20]  has  been  previously
documented.  IL8  enhances  healing  by  rapidly
chemoattracting leukocytes and fibroblasts into the wound
site [19]. We observed that PDGF increases IL8 chemokine
secretion twofold in human corneal fibroblasts, indicating that
IL8 is involved in PDGF-mediated corneal wound healing.
We  also  observed  that  AG-490,  a  selective  JAK/STAT
inhibitor,  significantly  suppressed  the  PDGF-induced  IL8
chemokine secretion levels in HSF (Figure 3). We did not
detect complete blocking of PDGF-mediated IL8 secretion at
100 μM concentration of AG-490. This could be due to the
lack of PDGF-mediated SOCS3 induction in the presence of
AG-490 (Figure 1) or the presence of alternative pathway(s)
for PDGF-mediated IL8 signaling.
Platelet-derived  growth  factor  mediates  cell  growth  and
migration  via  JAK2-STAT3  pathway:  Human  corneal
fibroblast cultures exposed to PDGF demonstrated 19%–30%
increase  in  corneal  fibroblast  proliferation  at  1  h  (30%,
p<0.001), 8 h (21%, p<0.001), and 48 h (19%, p<0.001; Figure
4).  As  seen  in  Figure  4,  treatment  of  AG-490  (100  μM)
significantly blocked PDGF-induced cell growth in HSF at 1
h (36%, not significant), 8 h (63%, p<0.01), and 48 h (68%,
p<0.001). Additionally, PDGF treatment increased corneal
fibroblast migration at two tested time points (1 h and 8 h). It
caused  a  142%  (p<0.001)  increase  in  corneal  fibroblast
migration at 8 h, and AG-490 (100 μM) treatment inhibited
37% (p<0.01) of the PDGF-induced cell migration at this time
point  (Figure  5).  However,  no  significant  change  in  cell
migration in response to PDGF was noted at 1 h (data not
shown).  This  data  suggest  that  JAK2-STAT3  signaling
pathway  is  involved  in  PDGF-induced  corneal  fibroblast
proliferation and migration (Figure 4 and Figure 5).
DISCUSSION
PDGF and their receptors are expressed in the cornea, and its
role in corneal wound healing is well established [16,27,31].
Figure  1.  PDGF-mediated  SOCS3  induction  in  human  corneal
fibroblasts  involves  JAK2-STAT3  pathway.  Human  corneal
fibroblasts were exposed to a mixture of PDGF (AA, AB, and BB)
at a final concentration of 20 ng/ml with or without JAK2-STAT3
inhibitor, AG-490 (final concentration of 100 μM) for 1 h or 8 h.
SOCS3  transcript  levels  were  quantified  by  real-time  PCR,  and
protein  levels  were  determined  by  immunoprecipitation  and
immunoblotting using the SOCS3 polyclonal antibody. A: The fold
change in SOCS3 transcript levels compared to untreated control is
shown  as  mean  ±SEM.  The  PDGF  treatment  increases  SOCS3
mRNA levels by threefold at 1 h and 4.5 fold at 8 h, and AG-490
treatment  inhibits  PDGF-induced  SOCS3  mRNA  levels
significantly. The asterisk indicates a p<0.05 versus control and the
double asterisk indicates a p<0.05 versus PDGF. B: SOCS3 protein
levels in PDGF-treated, BSA-treated or untreated cells showing 1.5
to 2.5 fold increase in SOCS3 protein expression by PDGF treatment.
Pre-immune  serum  was  used  as  a  negative  control  for
immunoprecipitation.
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1023However, the underlying mechanism through which PDGF
acts in the cornea is largely unknown. PDGF, upon binding to
the  receptors,  can  activate  numerous  signaling  pathways
including the tyrosine kinases from JAK and transcription
factors from the family of STAT proteins [38-43]. Binding to
tyrosine kinase family receptors leads to dimerization, auto
phosphorylation of tyrosine residues, and recruitment of a
variety of Src-homology 2 domains containing intracellular
proteins,  which  activate  downstream  pathways  such  as
mitogen activated protein (MAP) kinase, JAK/STAT, and PI3
kinase [38,41,42]. Multiple reports showed that STAT signals
Figure  2.  PDGF-mediated  STAT3  induction  in  human  corneal
fibroblasts  involves  JAK2-STAT3  pathway.  Human  corneal
fibroblasts were induced with the mixture of PDGF (AA, AB, and
BB) at a final concentration of 20 ng/ml for 1 h or 8 h in the presence
or absence of 100 μM AG-490. Protein levels were measured by
immunoblotting  using  a  polyclonal  STAT3  antibody.  PDGF
treatment significantly increased STAT3 protein expression by 2.5
fold (1 h) to 2.96 fold (8 h). β-Actin immunoblot shows the equal
loading in each lane.
Figure 3. PDGF induces IL8 chemokine secretion via JAK2-STAT3
pathway. Human corneal fibroblast cultures were serum-starved for
24 h and stimulated with PDGF in the presence or absence of JAK2-
STAT3 inhibitor, AG-490, for 8 h, and IL8 chemokine levels in
supernatants were measured by solid-phase sandwich ELISA. PDGF
induced  IL8  chemokine  secretion  (twofold),  and  AG-490
significantly  inhibits  IL8  secretion.  Data  are  shown  as  pg/ml
concentration. The asterisk indicates a p<0.01 versus control.
are under stringent regulation by a family of endogenous
negative  feedback  regulators  generically  called  SOCS
[44-46].  SOCS  proteins  bind  to  tyrosine-phosphorylated
receptors  and  non-receptor  tyrosine  kinases  and  prevent
recruitment  of  STATs  to  the  activated  receptor  complex
[44-46]
Although  the  role  of  PDGF  in  corneal  fibroblast
proliferation  and  migration  has  been  previously  reported
[27], it is unknown whether effects of PDGF in the cornea are
mediated through the activation of JAK2-STAT3 pathways
and whether its activity in this ocular tissue is regulated by
SOCS. Moreover, both PDGF and IL8 are chemoattractant
and contribute in corneal wound healing, but the role of PDGF
in IL8-mediated chemotaxis is not described [1,16,17]. This
is  a  first  report  to  demonstrate  that  PDGF  induces  IL8
chemokine  secretion  in  human  corneal  fibroblasts.  The
induction of IL8 facilitates an early innate immune response
to infection in the corneal stroma and represents an elementary
defense  mechanism  in  corneal  wound  healing  [29].  IL8
enhances healing by rapidly chemoattracting leukocytes and
fibroblasts  into  the  wound  site,  stimulating  the  latter  to
differentiate into myofibroblasts. In turn, myofibroblasts are
critical  for  wound  contraction  and  closure  and  for  the
production of extracellular matrix molecules, which leads to
precocious development of granulation tissue [21,47,48]. Our
data suggest that PDGF-mediated IL8 chemokine secretion
Figure 4. PDGF-induced cell proliferation involves JAK2-STAT3
pathway. Human corneal fibroblasts were exposed to PDGF in the
presence or absence of JAK2-STAT3 inhibitor, AG-490, for 1 h, 8
h, or 48 h, and cell proliferation was quantified using the MTT assay.
PDGF induced cell proliferation significantly in HSF, and AG-490
showed significant suppression of PDGF-induced cell proliferation.
Data are shown as mean ±SD of absorbance at 570 nm. The asterisk
indicates a p<0.001 versus control, the double asterisk indicates a
p<0.01 versus PDGF, and the triple asterisk indicates a p<0.001
versus PDGF.
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1024and cell growth and migration in corneal fibroblasts occur via
JAK2-STAT3 pathway. We observed that the JAK2-STAT3
inhibitor  (AG-490)  inhibits  PDGF  functional  activity  in
human corneal fibroblasts. A high (100 µM) concentration of
AG-490  did  not  completely  block  the  PDGF  functional
activity, suggesting the possibility of additional regulators in
PDGF-induced  cell  proliferation,  migration,  and  IL8
secretion. The role of signaling pathways like Ras-ERK, Akt,
and  PIP3-PKC  in  PDGF-mediated  cell  proliferation  and
migration has been shown earlier [49,50]. We observed that
PDGF induces both STAT3 and SOCS3 expression and that
the JAK2-STAT3 inhibitor suppresses SOCS3 expression in
human  corneal  fibroblasts.  This  observation  suggests  that
PDGF  activity  in  the  cornea  may  be  under  the  negative
feedback regulation of SOCS3 (Figure 6).
We  have  previously  shown  the  role  of  STAT1  in
keratocyte  apoptosis  that  occurs  in  response  to  corneal
epithelial injury using STAT1 null mice and proposed that
STAT1 could be a therapeutic target for transient inhibition
of keratocyte apoptosis to modulate corneal wound healing
[51]. Our gene array study showed time-dependent regulation
of  SOCS3  in  human  corneal  fibroblasts  stimulated  with
PDGF. Our study results suggest that SOCS3 has a role in
PDGF-mediated wound healing in the cornea [13]. Nagai et
al. [32] demonstrated the role of STAT3 and SOCS3 in skin
fibroblast cell migration. These authors noted nearly complete
inhibition of PDGF-mediated STAT3 phosphorylation and
over 50% decrease in cell migration in the skin fibroblasts that
were overexpressing SOCS3. Using the transgenic animal
approach,  Akira  and  his  coworkers  reported  that  STAT3
Figure  5.  PDGF-induced  cell  migration  involves  JAK2-STAT3
pathway. Human corneal fibroblasts were exposed to PDGF in the
presence or absence of JAK2-STAT3 inhibitor, AG-490, for 8 h, and
cell migration was quantified using the Boyden chamber chemotaxis
assay.  PDGF-induced  corneal  fibroblast  migration  was  inhibited
significatly by AG-490. The asterisk indicates a p<0.001 versus
control and the double asterisk indicates a p<0.01 versus PDGF.
modulates numerous biological activities including apoptosis,
cell  growth,  and  migration  [52].  We  report  that  PDGF-
mediated  cell  growth  and  migration  in  human  corneal
fibroblast involves STAT3-SOCS3.
IL8  gene  transcription  is  induced  by  various
proinflammatory  stimuli  such  as  lipopolysaccharide,  IL1β
and tumor necrosis factorα [34]. The half-life of IL8 mRNA
in human corneal fibroblast has been reported to be less than
1.5 h while neuropeptides like calcitonin gene-related peptide
and substance P have been shown to enhance its half-life by
increasing its mRNA stability [53]. Proinflammatory stimuli
are considered to be a major regulator of IL8 steady-state
levels in response to injury. IL8 has been shown to be involved
in many of the wound healing processes. It not only serves as
a chemotactic factor for leukocytes and fibroblasts but also
stimulates fibroblast differentiation into myofibroblasts and
promotes angiogenesis [47,48]. More studies are required to
investigate other components modulated by the IL8 in corneal
wound healing. Based on the involvement of JAK2-STAT3
pathway  in  PDGF-mediated  corneal  wound  healing,  we
predict that PDGF-induced IL8 chemokine secretion could be
one of the mechanisms that might be a critical mediator of
wound healing in the cornea.
In summary, this study demonstrates the mechanism of
PDGF-mediated corneal wound healing in vitro. The PDGF
induces  the  proliferation,  migration,  and  IL8  chemokine
Figure  6.  Schematic  of  PDGF-mediated  corneal  wound  healing.
PDGF secreted at the site of the corneal wound induces its receptors
on the corneal fibroblast that induces JAK2 followed by STAT3
phosphorylation  and  nuclear  translocation.  STAT3  induces  the
transcription of genes involved in cell growth, migration, and IL8
chemokine secretion resulting in the initiation of corneal wound
healing. SOCS3 serves as an endogenous regulator of JAK2-STAT3
inhibition as seen with the chemical inhibitor, AG-490, in vitro.
Molecular Vision 2008; 14:1020-1027 <http://www.molvis.org/molvis/v14/a122> © 2008 Molecular Vision
1025secretion in human corneal fibroblasts in part through the
JAK2-STAT3 signaling pathway. Additionally, we observed
that PDGF induces the expression of SOCS3 as a potential
mechanism  to  negatively  regulate  inflammatory  signaling
during corneal wound healing.
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